➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
McKesson
Baxter
Boehringer Ingelheim
Dow
Harvard Business School

Last Updated: July 11, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 203775


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

NDA 203775 describes CEVIMELINE HYDROCHLORIDE, which is a drug marketed by Apotex Inc, Hikma, Novel Labs Inc, and Rising, and is included in four NDAs. It is available from four suppliers. Additional details are available on the CEVIMELINE HYDROCHLORIDE profile page.

The generic ingredient in CEVIMELINE HYDROCHLORIDE is cevimeline hydrochloride. There are four drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the cevimeline hydrochloride profile page.
Summary for 203775
Tradename:CEVIMELINE HYDROCHLORIDE
Applicant:Rising
Ingredient:cevimeline hydrochloride
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 203775
Suppliers and Packaging for NDA: 203775
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CEVIMELINE HYDROCHLORIDE cevimeline hydrochloride CAPSULE;ORAL 203775 ANDA Rising Pharmaceuticals, Inc. 16571-657 16571-657-10 100 CAPSULE in 1 BOTTLE (16571-657-10)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength30MG
Approval Date:Jun 4, 2014TE:ABRLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
AstraZeneca
Express Scripts
Boehringer Ingelheim
Colorcon
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.